FDG18 or [18F]-2-fluoro-2-deoxy-D-glucose is an analogue of glucose and the main Positron Emission Tomography (PET) radiopharmaceutical that is primarily used for glucose metabolism applications with the help of a PET scanner..
BRIT provides FDG18 injection labelled with positron emitting short lived isotope of fluorine namely 18F-flourine, half-life 109.7 Minutes. FDG Finds major applications in glucose metabolism. The vial contains a sterile isotonic solution of radioactive [18F]-2-fluoro-2-deoxy-D-glucose injection, suitable for intravenous administration.
It contains not less than 90% and not more than 110 % of the labelled amount of 18F expressed in mCi per ml at the reference time. It may contain suitable preservative and/or stabilizing agents. FDG is to be stored at ambient temperature with appropriate shielding and has a shelf-life of 8 hours from the reference time.
Applications of FDG18 :